08:41 EDT 17th March 2018 | BioPortfolio

Our unique process matches breakthrough technology developed at Universities or Research Institutions with commercialization partners who validate the technology and the market potential, thus reducing risk and accelerating the technology to market. We establish and manage companies that hold exclusive licenses and rights to technology that has had significant research funding and that is ready to be commercialized. Our value add is to form partnerships with large international companies pursuing major markets and managing the development process to bring the technology, products and services to market in a timely manner


2508 Ashley Worth Blvd.Suite 200

United States of America


Phone: 512) 263-3232
Fax: 512) 263-3236

News Articles [245 Associated News Articles listed on BioPortfolio]

Emergent files paperwork for new immuno-oncology spin-off

Emergent BioSolutions announced April 15 that it has begun the formal process of separating some of its assets to form a separate entity, which will be known as Aptevo Therapeutics Inc. Read more..

$175.41 Million in Sales Expected for Emergent Biosolutions, Inc. (EBS) This Quarter

Equities analysts predict that Emergent Biosolutions, Inc. will announce sales of $175.41 million for the current quarter, Zacks reports. Two analysts have provided estimates for Emergent Biosolutions...

Emergent buys Abec bioreactor for BioThrax facility

Bioterrorism countermeasure manufacturer Emergent Biosciences has bought a 4,000L bioreactor developed by Abec.

Emergent buys Abec bioreactor to transfer raxibacumab to Baltimore facility

Bioterrorism countermeasure manufacturer Emergent Biosciences has bought a 4,000L bioreactor developed by Abec.

Emergent BioSolutions strengthens manufacturing infrastructure with FDA-licensure

The US Food and Drug Administration (FDA) has approved Emergent BioSolutionsâ supplemental Biologics License Application (sBLA) for the manufacture of ACAM2000, the only FDA-licensed smallpox vaccine...

Emergent wins approval to bring smallpox vaccine manufacturing to US

Emergent will transfer the upstream process for a former-Sanofi smallpox vaccine from a site in Austria to Massachusetts following US FDA approval.

Emergent files application to expand production of BioThrax

Emergent BioSolutions has filed a supplemental Biologics License Application with the U.S. Food and Drug Administration to scale up production of its anthrax vaccine BioThrax. Read more..

Emergent Order's Revelations of Waco Debuts on Paramount Network Multi-Platform

AUSTIN, Texas, Feb. 7, 2018/PRNewswire/ -- Austin, Texasproduction and creative agency, Emergent Order, has produced a series of six mini documentaries—titled Revelations of Read more...

PubMed Articles [468 Associated PubMed Articles listed on BioPortfolio]

Experience with Event Timing Does not Alter Emergent Timing: Further Evidence for Robustness of Event and Emergent Timing.

Although, event and emergent timings are thought of as mutually exclusive, significant correlations between tapping and circle drawing (Baer, Thibodeau, Gralnick, Li, & Penhune, 2013 ; Studenka, Zelaz...

Emergent cholecystectomy is superior to percutaneous cholecystostomy tube placement in critically ill patients with emergent calculous cholecystitis.

The role of percutaneous cholecystostomy (PC) is undefined in patients with multiple comorbidities presenting with emergent calculous cholecystitis (CC). This study compared outcomes between PC, lapar...

Telehealth and eHealth interventions for posttraumatic stress disorder.

This paper presents existing research describing how telehealth and eHealth technologies can be used to improve mental health services for trauma survivors, either by enhancing existing treatment appr...

What can Parents' Self-report of Reading Difficulties Tell Us about Their Children's Emergent Literacy at School Entry?

Research has linked family risk (FR) of reading difficulties (RD) with children's difficulties in emergent literacy development. This study is the first to apply parents' self-report of RD as a proxy ...

Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants.

Treatment-emergent affective switch (TEAS), including treatment-emergent mania (TEM), carry significant burden in the clinical management of bipolar depression, whereas the use of antidepressants rais...

Clinical Trials [483 Associated Clinical Trials listed on BioPortfolio]

Multifactorial Approach to Emergent Cerclage

Though cervical insufficiency is a common cause of second trimester pregnancy loss, the placement of an emergent cerclage in these patients is thought to improve perinatal outcomes. It is ...

Pre-hospital and Intra-hospital Temporal Delays in Patients Requiring Emergent Trauma Craniotomy

The investigators aim to retrospectively map the delays in the acute care of traumatic brain injury patients necessitating emergent craniotomies.

Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression

This study will develop a new methodology to evaluate any treatment-emergent suicidal ideation that might occur when an antidepressant treatment has been started and/or during times when d...

Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal

The goal of this study is to determine if a fixed dose of 4-factor prothrombin complex concentrate (4FPCC) is as effective as the current standard of care. 4FPCC is used to reverse the eff...

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

This is a randomized, active comparator-controlled, parallel-group, multi-site, double-blind safety trial of sugammadex (MK-8616) for the reversal of neuromuscular blockade (NMB) induced b...

Companies [1265 Associated Companies listed on BioPortfolio]

Emergent Health Corp.

Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. Using patented and patent pending nutritionally designed products, E...

Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodyâ€...

Emergent Financial Group, Inc.

Emergent Financial Group provides investment banking services for early stage growth companies in healthcare. By specializing on innovative healthcare companies, Emergent has deve...

Emergent Technologies, Inc.

Headquartered in Austin, Texas, Emergent Technologies, Inc. (Emergent) is a leading innovation solutions company that identifies, manages, develops and partners to turn game-chang...

Virtual Radiologic Corp.

Virtual Radiologic Corporation (vRad) is a national radiology practice working in partnership with local radiologists and hospitals to optimize radiology’s pivotal role in pa...

More Information about "EMERGENT TECHNOLOGIES, INC" on BioPortfolio

We have published hundreds of EMERGENT TECHNOLOGIES, INC news stories on BioPortfolio along with dozens of EMERGENT TECHNOLOGIES, INC Clinical Trials and PubMed Articles about EMERGENT TECHNOLOGIES, INC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EMERGENT TECHNOLOGIES, INC Companies in our database. You can also find out about relevant EMERGENT TECHNOLOGIES, INC Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record